Close
Back to RCUS Stock Lookup
Pages: 1 2 3 4 5 »» Last Page

(RCUS) – Press Releases

Apr 9, 2024 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Mar 26, 2024 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Mar 11, 2024 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Feb 28, 2024 04:05 PM Arcus Biosciences to Participate in Two Upcoming Investor Conferences
Feb 27, 2024 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Feb 21, 2024 04:05 PM Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
Feb 9, 2024 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Feb 7, 2024 05:00 PM Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates
Jan 29, 2024 05:00 PM Gilead and Arcus Announce Amended Collaboration and Equity Investment
Jan 26, 2024 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Jan 16, 2024 05:00 PM Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer
Dec 11, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Dec 4, 2023 08:00 AM Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma
Nov 27, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Nov 14, 2023 04:00 PM Arcus Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference
Nov 13, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Nov 7, 2023 04:01 PM Arcus Biosciences Reports Third Quarter 2023 Financial Results and Provides a Pipeline Update
Nov 6, 2023 05:00 PM Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-Line Treatment for Upper GI Cancers
Oct 24, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Oct 17, 2023 04:00 PM Arcus Biosciences to Present Data from Ongoing EDGE-Gastric Study at ASCO Plenary and to Report Third-Quarter Financial Results on November 7
Oct 10, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Sep 26, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Sep 11, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Aug 24, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Aug 23, 2023 09:00 AM Arcus Biosciences to Participate in Multiple Upcoming Investor Conferences
Aug 9, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Aug 7, 2023 08:00 AM Arcus Biosciences Reports Second-Quarter 2023 Financial Results and Provides a Pipeline Update
Jul 25, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Jul 11, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Jun 26, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Jun 9, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Jun 3, 2023 01:30 PM Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study
May 30, 2023 04:00 PM Arcus Biosciences to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
May 24, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
May 17, 2023 08:30 AM Presentations at the 2023 ASCO Annual Meeting Highlight Arcus Biosciences’ Expanding Portfolio of Investigational Medicines and Late-Stage Studies Across Multiple Types of Cancer
May 15, 2023 08:30 AM Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammation
May 9, 2023 04:05 PM Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update
May 8, 2023 04:35 PM Arcus Biosciences Announces New Employment Inducement Grants
Apr 25, 2023 04:05 PM Arcus Biosciences Announces New Employment Inducement Grants
Apr 11, 2023 04:05 PM Arcus Biosciences Announces New Employment Inducement Grants
Mar 9, 2023 04:05 PM Arcus Biosciences Announces New Employment Inducement Grants
Mar 2, 2023 04:00 PM Arcus Biosciences to Participate in the Barclays Global Healthcare Conference
Feb 28, 2023 04:05 PM Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update
Feb 24, 2023 04:05 PM Arcus Biosciences Announces New Employment Inducement Grants
Feb 9, 2023 04:05 PM Arcus Biosciences Announces New Employment Inducement Grants
Feb 6, 2023 04:05 PM Arcus Biosciences to Participate at Upcoming Virtual Investor Events
Jan 24, 2023 04:05 PM Arcus Biosciences Announces New Employment Inducement Grants
Jan 10, 2023 04:05 PM Arcus Biosciences Announces New Employment Inducement Grants
Dec 23, 2022 08:00 PM Arcus Biosciences Announces New Employment Inducement Grants
Dec 19, 2022 05:00 PM Anti-TIGIT Domvanalimab-Containing Study Arms Improve Progression-Free Survival Compared to Anti-PD1 Alone in Phase 2 Non-Small Cell Lung Cancer Study
Pages: 1 2 3 4 5 »» Last Page

Back to RCUS Stock Lookup